HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seok-Yong Lee Selected Research

6,7,4'-trihydroxyisoflavone

12/2019Protective effects of 6,7,4'-trihydroxyisoflavone, a major metabolite of daidzein, on 6-hydroxydopamine-induced neuronal cell death in SH-SY5Y human neuroblastoma cells.
5/20186,7,4'-Trihydroxyisoflavone, a major metabolite of daidzein, improves learning and memory via the cholinergic system and the p-CREB/BDNF signaling pathway in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seok-Yong Lee Research Topics

Disease

10Pain (Aches)
07/2022 - 01/2014
7Cognitive Dysfunction
10/2021 - 12/2010
6Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 01/2011
4Osteoarthritis
05/2022 - 03/2017
4Rheumatoid Arthritis
05/2022 - 03/2017
4Neoplasms (Cancer)
01/2022 - 05/2018
4Inflammation (Inflammations)
01/2021 - 11/2014
4Neuroblastoma
12/2019 - 04/2011
4Sleep Initiation and Maintenance Disorders (Insomnia)
09/2018 - 07/2012
3Hypertension (High Blood Pressure)
06/2022 - 07/2017
3Obesity
12/2019 - 03/2016
3Parkinson Disease (Parkinson's Disease)
07/2019 - 02/2014
3Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2018 - 02/2012
2Heart Failure
06/2022 - 12/2021
2Arthritis (Polyarthritis)
01/2022 - 11/2014
2Neuroinflammatory Diseases
12/2021 - 01/2020
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
11/2021 - 11/2012
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2020 - 01/2020
2Overactive Urinary Bladder (Overactive Bladder)
12/2017 - 11/2017
2Mitochondrial Diseases (Mitochondrial Disease)
07/2014 - 03/2012
1Ischemic Stroke
12/2021
1Lower Urinary Tract Symptoms
11/2021
1Schizophrenia (Dementia Praecox)
10/2021
1Animal Disease Models
10/2021
1Dysmenorrhea (Menstrual Pain)
07/2021
1Drug-Related Side Effects and Adverse Reactions
07/2021
1Acute Pain
07/2021
1Ankylosing Spondylitis
07/2021
1Mood Disorders (Mood Disorder)
03/2021
1Motor Disorders
11/2020
1Hyperglycemia
01/2020
1Nephritis
11/2019
1Hyperpigmentation
11/2019
1Angioedema
10/2019
1Fibrosis (Cirrhosis)
01/2019

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
05/2022 - 07/2017
6Scopolamine (Hyoscine)FDA Link
08/2019 - 12/2010
5Proteins (Proteins, Gene)FDA Link
12/2021 - 07/2012
4Morphine (MS Contin)FDA LinkGeneric
07/2022 - 09/2014
4Oxidopamine (6 Hydroxydopamine)IBA
12/2019 - 02/2014
3Monoclonal AntibodiesIBA
01/2020 - 01/2014
3Brain-Derived Neurotrophic Factor (BDNF)IBA
08/2019 - 10/2017
3Cholinergic Agents (Cholinergics)IBA
08/2019 - 10/2017
3Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
01/2018 - 02/2012
3Neuroprotective AgentsIBA
06/2015 - 12/2010
2Angiotensin Receptor AntagonistsIBA
12/2021 - 07/2017
2LipopolysaccharidesIBA
12/2021 - 01/2020
2Ion Channels (Ion Channel)IBA
12/2021 - 01/2021
2Tamsulosin (Flomax)FDA LinkGeneric
11/2021 - 11/2012
2Adrenergic Receptors (Adrenergic Receptor)IBA
11/2021 - 11/2012
2Cytochrome P-450 CYP2C9IBA
07/2021 - 08/2018
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
07/2021 - 03/2017
2Celecoxib (Celebrex)FDA Link
07/2021 - 03/2017
2Therapeutic UsesIBA
03/2021 - 11/2019
2AcidsIBA
01/2020 - 11/2014
26- chloro- 2,3,4,9- tetrahydro- 1H- carbazole- 1- carboxamideIBA
01/2020 - 01/2020
2CytokinesIBA
01/2020 - 01/2020
2daidzeinIBA
12/2019 - 05/2018
26,7,4'-trihydroxyisoflavoneIBA
12/2019 - 05/2018
2Zolpidem (Ambien)FDA LinkGeneric
08/2018 - 04/2015
2Paclitaxel (Taxol)FDA LinkGeneric
02/2018 - 02/2018
2Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2018 - 02/2014
2Muscarinic AntagonistsIBA
12/2017 - 11/2017
2Tolterodine Tartrate (Detrol)FDA Link
12/2017 - 11/2017
2TeaIBA
03/2016 - 07/2012
2CholesterolIBA
03/2016 - 08/2011
2NeurotoxinsIBA
07/2014 - 02/2014
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
07/2012 - 04/2011
2loganinIBA
03/2011 - 10/2009
1Messenger RNA (mRNA)IBA
07/2022
1EnzymesIBA
06/2022
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
06/2022
1Metoprolol (Toprol-XL)FDA LinkGeneric
06/2022
1Piroxicam (Feldene)FDA LinkGeneric
05/2022
1Meloxicam (Mobic)FDA LinkGeneric
12/2021
1LigandsIBA
12/2021
1candesartan cilexetil (Amias)FDA Link
12/2021
11- (1- (2- methoxyphenyl)- 2- phenylethyl)piperidineIBA
10/2021
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
07/2021
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
03/2021
1AnkyrinsIBA
01/2021
1Metoclopramide (Reglan)FDA LinkGeneric
11/2020
1AntiemeticsIBA
11/2020
1EstersIBA
01/2020
1bardoxolone methylIBA
01/2020
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2020
1Radioisotopes (Radionuclides)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Amyloid (Amyloid Fibrils)IBA
11/2019
1icatibantIBA
10/2019
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2019
1homoorientin (isoorientin)IBA
08/2019
1AntioxidantsIBA
08/2019
1FlavonoidsIBA
08/2019
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
07/2019
1Hydroxyproline (4 Hydroxyproline)IBA
01/2019
1Thioacetamide (Thioacetamid)IBA
01/2019
1Collagen Type I (Type I Collagen)IBA
01/2019
1VimentinIBA
01/2019

Therapy/Procedure

1Precision Medicine
07/2021